These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15161050)

  • 1. Simultaneous measurement of nucleolin and estrogen receptor in breast cancer cells by laser scanning cytometry.
    Masiuk M; Urasinska E; Domagala W
    Anticancer Res; 2004; 24(2B):963-6. PubMed ID: 15161050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranuclear nucleolin distribution during cell cycle progression in human invasive ductal breast carcinomas in relation to estrogen receptor status.
    Masiuk M; Urasinska E; Domagala W
    Anticancer Res; 2007; 27(6B):3957-62. PubMed ID: 18225556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the biotinylated antibody DAKO-ER 1D5 to measure oestrogen receptor on cytokeratin positive cells obtained from primary breast cancer cells.
    Brotherick I; Lennard TW; Cook S; Johnstone R; Angus B; Winthereik MP; Shenton BK
    Cytometry; 1995 May; 20(1):74-80. PubMed ID: 7541332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays.
    Pertschuk LP; Feldman JG; Kim YD; Braithwaite L; Schneider F; Braverman AS; Axiotis C
    Cancer; 1996 Jun; 77(12):2514-9. PubMed ID: 8640700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser scanning cytometry quantification of estrogen receptors in breast cancer.
    Gorczyca W; Davidian M; Gherson J; Ashikari R; Darzynkiewicz Z; Melamed MR
    Anal Quant Cytol Histol; 1998 Dec; 20(6):470-6. PubMed ID: 9870098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study].
    Zhou ZW; Wan DS; Wang GQ; Pan ZZ; Lu HP; Gao JH; Ding PR
    Ai Zheng; 2004 Jul; 23(7):851-4. PubMed ID: 15248927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of ploidy and steroid receptor status in breast cancer by laser scanning cytometry.
    Bollmann R; Torka R; Schmitz J; Bollmann M; Méhes G
    Cytometry; 2002 Aug; 50(4):210-5. PubMed ID: 12210600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
    J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of computer-assisted image analysis and light-microscopically determined estrogen receptor status of breast carcinomas.
    Bejar J; Sabo E; Misselevich I; Eldar S; Boss JH
    Arch Pathol Lab Med; 1998 Apr; 122(4):346-52. PubMed ID: 9648904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogen receptor (ER) status of breast cancer cells. I. Classification of breast cancer cells bound with fluoresceinate-estrogen].
    Zheng S
    Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):420-2. PubMed ID: 3915457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.
    Sharma P; Kimler BF; Warner C; Metheny T; Xue Q; Zalles CM; Fabian CJ
    Breast Cancer Res Treat; 2006 Nov; 100(1):71-6. PubMed ID: 16791479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
    J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
    Neven P; Van Calster B; Van den Bempt I; Van Huffel S; Van Belle V; Hendrickx W; Decock J; Wildiers H; Paridaens R; Amant F; Leunen K; Berteloot P; Timmerman D; Van Limbergen E; Weltens C; Van den Bogaert W; Smeets A; Vergote I; Christiaens MR; Drijkoningen M
    Breast Cancer Res Treat; 2008 Jul; 110(1):153-9. PubMed ID: 17687649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and intranuclear distribution of nucleolin in HL-60 and K-562 cells after repeated, short-term exposition to rotating magnetic fields.
    Masiuk M; Rakoczy R; Masiuk S; Kordas M
    Int J Radiat Biol; 2008 Sep; 84(9):752-60. PubMed ID: 18821389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.
    Kurbel S
    Med Hypotheses; 2005; 64(6):1182-7. PubMed ID: 15823713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.
    Esslimani-Sahla M; Simony-Lafontaine J; Kramar A; Lavaill R; Mollevi C; Warner M; Gustafsson JA; Rochefort H
    Clin Cancer Res; 2004 Sep; 10(17):5769-76. PubMed ID: 15355905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.